Prognostic significance of HIF-2&alpha;/EPAS1 expression in hepatocellular carcinoma

doi:10.3748/wjg.v13.i23.3176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5655)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

512

HTML

4652

Figures (1-2)

265

Tables (1-4)

226

Sum=5655

Jun 21, 2007 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (87)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jun 21, 2007; 13(23): 3176-3182
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3176

Full Size Figure Download Figure

Figure 1 Representative examples of immunohistochemical staining for HIF-2α/EPASE1, VEGF, and CD31 in HCC. A: Strong cytoplasmic immunore-activity of HIF-2α/EPASE1 is observed in cancers cells (× 400). B: Strong staining in the cytoplasm of noncancerous cirrhotic tissue (× 400). C: HIF-2α/EPAS1-positive staining in perinecrotic area (N) and D: In the cytoplasm of macrophages (× 400). E: Parallel studies of VEGF protein (cytoplasmic staining) and F: CD31 (for microvessels) immunohistochemistry performed on HCC (× 200).

Citation: Bangoura G, Liu ZS, Qian Q, Jiang CQ, Yang GF, Jing S. Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 2007; 13(23): 3176-3182
URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3176.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3176